Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumors

New candidate APVO455 targets Nectin-4+ cancers, joins mipletamig (AML) and APVO442 (prostate) in Aptevo's tumor-directed CD3 suite

Formulated with antioxidant-rich nutrients and nano-delivery technology, LuminEye aims to support visual clarity, eye hydration, and night vision comfort without synthetic additives.

This collaboration underscores CliniOps' continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies.

With the launch of a new initiative, The Longevity Center is providing veterans with immediate access to discounted SGB therapy for PTSD and other trauma-related conditions

Formulated with lutein, zeaxanthin, bilberry, and saffron, the plant-based iGenics supplement delivers targeted nutritional support for digital eye strain, blue light exposure, and long-term macular wellness.

HealthRX's direct-access platform eliminates insurance roadblocks by offering overnight delivery of doctor-prescribed GLP-1 weight loss medications like Ozempic® and semaglutide-backed by licensed physicians, transparent pricing, and real results.

Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board.

23-Ingredient Liver Detox Formula Combines Science-Backed Botanicals and Antioxidants to Support Energy, Digestion, and Long-Term Liver Function in 2025

Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1's effects on key drivers of accelerated aging

85% remission rate observed in evaluable frontline AML patients

Mipletamig combination enables rare pathway to transplant in a previously ineligible unfit patient

No dose-limiting toxicities observed among evaluable patients; safety profile remains strong

Evidence mounts for mipletamig as a potentially transformational addition to standard of care in frontline AML as targeted CD123 x CD3 approach showing power and precision, limited added toxicity

Mipletamig Trial Momentum Builds as Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy

Regulatory Approval by the UK Financial Conduct Authority was Key Requirement for Transaction Timing

Minimal Conditions Remain for Deal Completion; Closing Expected in July, 2025

With more than 10,000 procedures performed, Dr. Naderi discusses the technical demands and aesthetic advantages of non-surgical rhinoplasty using dermal fillers.

Safe, Reliable Wheelchair Transportation for Seniors and People with Disabilities - Book Your Ride Today

• New subsidiary, Cynaptec Pharmaceuticals, established to hold global rights to Conjugated Psilocin™

• $6 million investment in Cynaptec Pharmaceuticals secured to advance research and early-stage clinical trials for chronic cluster headaches and addiction

• Option for an additional $20 million investment in Cynaptec Pharmaceuticals to support Phase 3 clinical development

A Deep Dive Into the Botanical Science, User Testimonials, and Safety Standards Behind Lung Clear Pro's Natural Respiratory Support Formula

Need a Ride to Your Medical Appointment? Diamond Care Transportation Offers Safe, On-Time NEMT Services for Seniors and Disabled Patients in South Carolina

Explore the natural formula behind Blood Pressure 911-PhytAge Laboratories' most trusted supplement for promoting heart health, improving circulation, and supporting healthy blood pressure levels in 2025.

• Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024

• Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024

• EBITDA loss improved 59% in Q4 2025 compared to Q4 2024, and 17% in FY 2025 compared to FY 2024

New surgical kits, a 6.0-mm implant and upgraded accessories elevate the clinical ease and versatility of Glidewell's flagship system.

Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and Semiconductors

Key VELDONA® Human Clinical Studies Secure Taiwan Regulatory Greenlight, Accelerating Development

Florida House Bill passes a bill allowing allopathic physicians & osteopthic physicians to perform stem cell therapies with newly revised guidelines!

Quilt Health expands its mission to streamline clinical trial recruitment, enhance patient access to therapies and strengthen provider networks for sickle cell disease

Desert Oasis Healthcare has been named Large Business of the Year by the Greater Coachella Valley Chamber of Commerce, recognizing the organization’s exceptional leadership, innovation, and unwavering commitment to the health and well-being of the communities it serves.

Innovative New Metrics Enable Precise Vendor Assessment, Reflecting AI Adoption, Strategic Outsourcing, and Financial Stability Amid Regulatory and Economic Shifts

Younger People are Leading a Cultural Shift Toward Small, Natural-Looking Changes, Such as Baby Botox and Mini Facelifts, and Gruber Plastic Surgery is Ready to Meet the Demand

National Leaders in Hospital Genomic Surveillance Join in Key Advisory Roles as NGD Prepares to Deploy Real-Time Sequencing-Based Detection of Transmission in Hospitals

World Taste & Smell Day Spotlights $11 Trillion Opportunity to Transform Global Health Through Sensory Wellness

Comprehensive Rankings Leveraging Innovative KPIs Including AI Integration, Outsourcing Capabilities and Financial Resilience to Provide the Definitive Methodology for True Client Satisfaction in RCM

Leading gynecologic surgery practice brings its expert team and integrative, patient-first approach to a state-of-the-art outpatient setting in the heart of Manhattan.

Company expands sales force, engineering talent, patent portfolio, and implements 24/7 customer service amidst surging demand for AI-powered structural heart solutions.

European Firms Rise Above Hundreds of HIT Exhibitors for Scalability, Regulatory Alignment, and High-Growth Market Readiness

Data brief analyzes patenting and pricing practices for blockbuster drugs Eliquis and semaglutide medications (Ozempic, Rybelsus, Wegovy), continuing the acclaimed Overpatented, Overpriced series that exposes flaws in the U.S. patent system

VBRO technologies emerge as essential investments for payers navigating CMS and state-driven payment reforms, according to 849 executives polled pre-AHIP 2025

AI Nose Platform Advances Toward Scaled Pilot Programs Across Healthcare, Robotics, and Industrials

VELDONA® Oral Interferon Receives Approval to Begin Human Trials in Taiwan

New Clinical-Grade Essential Oil Solution Delivers Powerful Natural Support for Nail Clarity, Skin Comfort, and Long-Term Fungal Resistance Backed by Science and Wellness Trends in 2025

Natural Glucose Support Solution Combines Traditional Herbal Wisdom with 2025 Wellness Trends for Daily Blood Sugar Management Without Lifestyle Disruption